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SummARy
Background: Several tooth whiteners are available on the 
market, and the ideal choice should be determined by ef-
ficacy and optimal clinical results. 
objectives: The purpose of this study was to compare the 
reported clinical success rates of different tooth whitening 
products. 
search strategy: The relevant literature (1998 - 2011) 
was studied, using as sources the databases: Google 
Scholar, Science Direct, Medline and Pubmed. 
selection criteria: The material was clearly identified, the 
manufacturers’ instructions were respected and the sample 
size stated. 
results and conclusions: This descriptive report on 49 
papers focuses on the total colour change, measured with 
a calibrated shade guide and also numerically (colourime-
ter, chromameter or spectrophotometer), the relapse of the 
colour change and tooth sensitivity. in general, the dentist-
supervised at-home bleaching and the in-office treatment 
gave approximately the same initial percentage improvement 
of tooth whitening. However, the relapse after a four week or 
longer period was significantly higher for the in-office treat-
ment. The treatment of choice should be a dentist super-
vised at-home bleaching product which generally contains 
~10% carbamide peroxide applied over about 14 days for 
about eight hours per night. Tooth sensitivity should not be 
a general problem although some subjects might choose to 
discontinue treatment as a result of sensitivity.
bAckgRound
Dentists in clinical practice are faced with a large number of 
tooth whiteners available and advertised on the market. Fur-
thermore, they are bombarded with results based on labora-
tory studies and to a lesser extent on clinical studies.1-4 How 
then does the dentist select a tooth whitener which will be 
effective and provide optimal clinical results? important also 
is the extent of colour relapse over time.
Peroxide is the chemical most frequently used as a tooth 
whitening agent with two types being generally employed i.e. 
hydrogen peroxide (H
2
O
2
) or carbamide peroxide (CH
6
N
2
O
3
). 
Due to the instability of hydrogen peroxide it is mostly added 
to the whitener just before the application process, while 
carbamide peroxide is the more stable oxidising agent and 
can be included in the whitener itself. Thus, the hydrogen 
peroxide can be applied directly to the tooth surface as 
such or is produced from carbamide peroxide (CH
6
N
2
O
3
, 
or CH
4
N
2
O. H
2
O
2
) which dissociates into hydrogen peroxide 
(H
2
O
2
) and urea (N
2
H
4
CO) upon contact with water.5,6 Urea 
further breaks down into ammonia and carbon dioxide. it 
has been reported7 that a 10% carbamide peroxide solu-
tion can produce only about 3 – 3.35% hydrogen peroxide. 
Hydrogen peroxide is a very strong oxidising agent. When 
it decomposes it forms free radicals (O˙ and HO
2
˙)5,6 which 
are responsible for the strong bleaching effect on organic 
and inorganic chemicals in and on enamel and dentine. 
However, more of the stronger per-hydroxyl (HO
2
˙) radical is 
formed in alkaline mediums with a resulting higher bleaching 
effect on teeth.6
To the public, the most important aspects of tooth whiteners 
are the effectiveness of the whitener, how long lasting is the 
effect, the cost of the treatment and the duration of the re-
quired treatment. Therefore, if money is not an issue, the in-
office treatment would basically be the treatment of choice, 
since the resultant whitening effect can be observed just 
after the chair session.
 
Tooth-bleaching or tooth–whitening is mainly performed 
according to four different protocols: 1) dentist-supervised 
at-home bleaching, 2) in-office bleaching, 3) over-the-
counter whitening products for self-application and 4) com-
bination therapy (in-office followed by at-home treatment). 
in general, the most effective would be the first two, as 
the peroxide concentrations and application time of over-
the-counter products are simply too low. in contrast, the 
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Table 1: Shade Guide Measurements
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1 Browning 20088
Opalescence PF 
(plus nitrate and 
fluoride)
10%  - At-home 2 weeks / x6 hours per night 45% 88% 14%
2 Browning 20088
Opalescence 
formulation (F)
10% - At-home 2 weeks / x6 hours per night 62% 83% 0%
3 Matis, 19989
Opalescence Tooth 
Whitening Gel
10% - At-home 2 weeks/8 hrs per night mild 73% 41%
4 Matis, 200010 Opalescence F 15% - At-home 2 weeks/8 hrs per night  - 69% 18%
5 Matis, 200711 Opalescence PF 15%  - At-home 2 weeks/8 hrs per night mild 67% 24%
6 Mokhlis, 200012 Day White - 7.5 At-home 2 weeks/1hour twice a day mild 67% 13%
7 Mokhlis, 200012
Opalescence Tooth 
Whitening Gel PF
20% - At-home 2 weeks/ 1hour X2 daily - 67% 11%
8 Zekonis, 200313
Opalescence Tooth 
Whitening gel
10%  - At-home 2 weeks/8 hrs per night mild 67% 46%
9 Matis, 200010
Opalescence 
Dental Whitening 
Agent
10% - At-home 2 weeks/8 hrs per night  - 64% 15%
10 Matis, 200711 Nite White 16%  - At-home 2 weeks/8 hrs per night mild 63% 55%
11 Deliperi, 200414
Opalescence Xtra 
Boost plus Opales-
cence PF
10% 38%
in-office & 
At-home
3 days (30 min in-office / 60 
min at home
none 56% - 
12 Gurgan, 200915
Oplasecence Xtra 
Boost
 - 38% in-office X2 /15 min  - 54% - 
13 Matis200716 Brite Smile - 15% in-office 3 X 20 min  - 54% 68%
14 Gurgan, 200915
Laser-White 1--La-
ser Smile
 - 37% in-office X3 /8 min mild 54%  -
15 Gurgan, 200915 By White-Biowhite  - 38% in-office X2 / 20 min  - 53% - 
16 Deliperi, 200414
Opalescence Xtra 
plus Opalescence 
PF
10% 35%
in-office & 
At-home
3 days (30 min in-office / 60 
min at home
none 53% - 
17 Gurgan, 200915
Remewhite-Reme-
cure
- 35% in-office X3 / 20 min  - 53%  -
18 Giniger, 200517
ACP containing 
bleaching gel
16% - At-home 2 weeks / 3 hours per day mild 51% - 
19 Browning, 200418
Experimental 
Product E
10%  - At-home 2 weeks / 6 hours per night mild 50% 0%
20 Swift, 199919
Nupro Gold bleach-
ing gel
10%  - At-home 2 weeks / 8 hours per night - 50% 0%
21 Giniger, 200517
Nite White Excel 3 
Regular
16%  - At-home 2 weeks / 3 hours per day  - 48%  -
22 Kihn, 200020
Nupro Gold bleach-
ing gel
10%  - At-home
2 weeks / at least 4 hours 
per night
- 48% - 
23 Heymann, 199821
Colgate Platinum 
Professional Over-
night Whitening 
System
10% - At-home 1 week / 8 hours per night mild 47%  
24 Matis, 200716 PolaOffice  - 35% in-office X3 / 12 min  - 47% 69%
25 Matis, 200716 One-hour Smile - 35% in-office X3 /15 min - 44% 54%
26 Zekonis, 200313 StarBrite 35%  - in-office X2 / 3x10min mild 44% 32%
27 Cibirka, 199922 Opalescence 10%  - At-home 2 weeks / 8 hours per night - 44% - 
28 Matis, 200716 Niveous - 25% in-office 3 X 15 min  - 43% 72%
29 Matis, 200716 ArcBrite  - 30% in-office 3 X 20 min - 41% 53%
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Table 1: Shade Guide Measurements (continued)
1 2 3 4 5 6 7 8 9 10
30 Matis, 200716 Zoom!  - 25% in-office X3 / 20 min  - 39% 50%
31 Matis, 200716 Accelerated  -
40% and 
30%
in-office 5 X 3 Min  - 39% 81%
32 Li, 200523
Opalescence 
Treswhite
- 9% At-home 10 days / x1 hour daily mild 38% - 
33 Auschill, 200524 Opalescence PF 10%  - At-home 1 week / 8 hours per night  - 38% - 
34 Auschill, 200524
Opalescence Xtra 
Boost
 - 38% in-office 3 times / 15 min per time - 38%  -
35 Auschill, 200524 Whitestrips  - 5.3 At-home 2 weeks / 30 min twice daily  - 38% - 
36 Zantner, 200625 Odol-med3 gel  -  - at-home 2 weeks / X2 daily for 10 min none 33% 0%
37 de la Pena, 200626
Opalescence 
Ultradent
10% - At-home 4 weeks / 3 hours daily mild 31% - 
38 de la Pena, 200626 FKD (Kin Lab)  - 3.5 At-home 4 weeks / 3 hours daily mild 31%  -
39
Calatayud, 
200927
Vivastyle Paint on 
Plus
- 6% At-home 10 days / X1 daily for 10 min  - 30%  -
40
Calatayud, 
200927
Vivastyle Paint on 
Plus
 - 6% in-office
2 sessions 1 week apart/ 5 
times 10 min
 - 29%  -
41 Kugel, 200028 Crest Whitestrips - 5.3 At-home 2 weeks / X2 daily for 30 min - 28%  -
42 Zantner, 200625
Colgate Simply 
White
- 5.9 at-home 2 weeks / X2 daily for 15 min none 28% 3%
43 Abu Alenain, 200929
Opalescence 
Treswhite
 - 9% At-home 1 week / 60 min per day mild 28% - 
44 Matis, 200716 illumine  - 15% in-office X3 / 20 min  - 25% 18%
45 Cibirka, 199922 Nite White Excel 10%  - At-home 2 weeks / 8 hours per night  - 25%  -
46 Hannig, 200730 Whitestrips  - 6% At-home 2 weeks / X2 daily for 30 min mild 24%  -
47 Hannig, 200730 Vivadent Vivastyle 10%  - At-home 2 weeks / x1 daily for 60 min mild 24%  -
48
Abu Alenain, 
200929
White-Smile 10% - At-home 1 week / 2 hours daily mild 21%  -
49 Al Shethri, 200331 Star Brite - 35% in-office
2 treatments 1 week apart /
X3 daily for 10 min
mild 21% - 
50
Bernardon, 
201032
Whiteness HP 
maxx FGM
- 35% in-office
2 sessions, 3 applications per 
session, 15 day interval
- 21%  -
51 Al Shethri, 200331
Opalescence Xtra 
Boost
- 38% in-office
2 treatments 1 week apart /
X3 daily for 10 min
mild 20%  -
52
Bernardon, 
201032
Whiteness HP 
maxx FGM
 - 35% in-office
2 sessions / 3 applications of 
15 min / 15 day interval
 - 19%  -
53
Bernardon, 
201032
Whiteness Perfect 
FGM
10%  - At-home 2 weeks/8 hrs per night - 19% 0%
54 Leonard, 200133
Nightguard vital 
bleaching
10% - At-home 2 weeks / 8 hours per night mild 19% 0%
55 Meireless, 200834 Whiteness Perfect 10% - At-home 3 weeks / X2 hours daily - 14% 9%
56 Meireless, 200834 Whiteness Perfect 16%  - At-home 3 weeks / x2 hrs daily - 13% 2%
57
dos Santos, 
200835
Opalescence PF 10% - At-home 3 weeks / 8 hours per night 36% 13% - 
58 Braun, 200636 Voco CP solution 
0%
(Con-
trol)
- At-home 1 week / 2 hours daily - 10%  -
59 Abu, 200929
CleverWhite over-
the-counter 
-  6% At-home  1 week / 30 min per day mild 8% - 
60 Braun,200636 Voco CP solution 10%  - At-home 1 week / 2 hours daily  - 8% - 
61 Braun, 200636 Voco CP solution 17%  - At-home 1 week / 2 hours daily - 7% - 
Column 1: Study number
Column 2: Author(s)     
Column 3: Product tested
Column 4: % age carbamide peroxide
Column 5: % age hydrogen peroxide     
Column 6: Category of bleaching (at home, in office,  combination)
Column 7: Schedule of bleaching process
Column 8: Resultant tooth sensitivity
Column 9: immediate tooth colour improvement
Column 10: Relapse after four weeks or longer
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peroxide concentrations (~35%) of the in-office bleaching 
whiteners are high (Table 1)8-36 and applied for short bursts 
of time (~30 minutes) which might be repeated in the same 
session (or occasionally over more sessions) to show the ef-
fect before the patient goes home. Alternatively, the dentist-
supervised at-home bleaching process normally makes use 
of lower peroxide concentrations (~10% carbamide perox-
ide) and patient self-application at-home, mostly over-night 
and over several days, for a good result.
objectIveS
The objective of this study was firstly to evaluate and com-
pare the clinical success rates of different commercially 
available tooth whitening products as reported in selected 
clinical trials in which the application was effected according 
to the instructions of the manufacturer. Secondly, to thereby 
enable clinicians to make an informed decision regarding the 
choice of the products which are most clinically effective. 
SeARch StRAtegy
This was accomplished by means of a comprehensive study 
of the literature which had reported on relevant clinical tri-
als between 1998 and 2011, using the databases: Google 
Scholar, Science Direct, Medline and Pubmed respectively, 
with any combination of the keywords: tooth whitening, tooth 
bleaching, clinical studies, at-home, and in-office. The search 
was performed only on published, peer-reviewed articles.
cRIteRIA FoR SeLectIon oF StudIeS
The papers included were clinical studies in which:
the whiteners had been applied according to the manu-•	
facturers’ instructions. (The performance of the product 
could then be fairly evaluated in the circumstances un-
der which it was expected to be applied in practice); 
the brand name of the tooth whitener was clearly specified; •	
the sample size had been recorded. •	
Reporting the degree of relapse was not a criterion for inclu-
sion, nor was assessment of tooth sensitivity, although, in 
the small number of cases where it was measured, the latter 
data were recorded on a word ordinal scale and in some 
cases as a percentage. 
ASSeSSIng coLouR chAngeS
Basically, there are two different ways to measure the effect of 
tooth whiteners, namely, by means of matching with a calibrat-
ed shade guide or numerically (colourimeter, chromameter or 
spectrophotometer). Some papers provided the shade guide 
assessments and some, numerical values, while a few pro-
vided both. These varied methods of reporting complicated the 
summary of the research results. Evaluations using a shade 
guide are subjective, while the numerical measurements are 
objective, providing more reliable and accurate results.1,2 Most 
important are the improved accuracy and the quantification of 
colours by measurement in a three dimensional colour space, 
of which the L*a*b* (also known as the CiELAB3) is presently the 
most popular for the measurement of tooth colour (Figure 1). in 
this space L* indicates lightness/darkness (white/black), a* var-
ies from green (negative side) to red (positive side), while the b* 
value varies from blue (negative side) to yellow (positive side).4 
(The asterisk is used to differentiate the CiELAB system from 
previous colour space descriptions.) As with the shade guide, 
colour change measurements with the spectrophotometer can 
be given in one value, namely the ∆E*ab (Minolta), where ∆E*ab 
= [(∆L*)2 + (∆a*)2 + (∆b*)2]1/2 and ∆L*, ∆a* and ∆b* provide the 
changes which occurred in these components.
 
mAteRIALS And methodS 
Based on the above selection criteria a total of ~49 full-length 
published articles were included. Most of these articles report-
ed on two or more studies on different products and some 45 
products had been tested. All data were recorded in Excel® 
tables. The variables for which data were sought are as follows: 
Product name; percentage carbamide peroxiCP) and hydro-
gen peroxide (HP); Category (in-office or at-home bleaching); 
Application method; Tooth Sensitivity; percentage colour im-
provement; total colour change obtained immediately after the 
treatment process; percentage colour relapse after 4 weeks; 
and ∆E*ab after treatment. Where the percentage colour im-
provement or relapse was not given, it was calculated from the 
results. These results were summarised in two tables (1 and 2). 
Table 1 reflects data according to shade guide measurements 
and Table 2 those according to numerical values (spectropho-
tometer, chromameter and colourimeter).
 
Each study included a number of trials from which the spe-
cific authors had calculated an average for their sample for 
colour changes. To gain an impression of the average ef-
ficacy in tooth whitening achieved by the products under 
test, the reported averages were added and an average of 
the averages derived. These data were used to compare the 
general efficacy of in-office and at home treatments. 
ReSuLtS
Table 1 provides a summary of the results reported (or cal-
culated) in the selected clinical studies assessing the effica-
cy of tooth bleaching through shade guide assessments.8-36 
The data were sorted from the highest to lowest percentage 
perceived colour improvement just after bleaching accord-
ing to column 9 and the studies were numbered (column 1). 
The percentage colour relapse after a four week or longer 
period had been assessed and was recorded in column 10. 
in a few studies where both the shade guide and ∆E*ab val-
ues were given in a study, the average percentage improve-
ment of the two was calculated and noted (Table 1).
Table 22,4,9-13,15,16,25,31,32,34,37-45 includes the same columns as 
for Table 1, except Column 9 now shows the ∆E*ab values 
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Figure 1: Representation of colour solid for L*a*b* colour space from Minolta.3
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Table 2: Numerical measurements
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1 Zekonis, 200313 Opalescence Tooth Whitening gel 10% - At-home 2 weeks / 8 hrs per night mild 12.32 46
2 Matis , 200010 Opalescence F 15%  - At-home 2 weeks / 8 hrs per night  - 11.03  -
3 Matis, 200711 Opalescence PF 15% - At-home 2 weeks / 8 hrs per night mild 9.57 57
4 Tsuburu, 200537 Polanight 10% - At-home 2 weeks / 8 hrs per night mild 9.23  -
5 Mokhlis, 200012 Day White - 7.50% At-home 2 weeks / 1hour twice a day mild 9.2  -
6 Matis, 200010
Opalescence Dental Whitening 
Agent
10% - At-home 2 weeks / 8 hrs per night - 8.79 - 
7 Matis, 19989 Opalescence Whitening Gel 10% - At-home 2 weeks / 8 hrs per night mild 8.6 41
8 Bernardon, 201032 Whiteness Perfect FGM 10%  - At-home 2 weeks / 8 hrs per night  - 8.4 0
9 Zantner, 200625 Colgate Simply White  - 5.90% At-home 2 weeks / X2 daily for 15 min none 8.38 3
10 Zantner, 200625 Odol-med3 gel chlorite chlorite At-home 2 weeks / X2 daily for 10 min none 8.22 0
11 Matis, 200716 Niveous - 25% in-office 3 X 15 min  - 8.1 72
12 Matis, 200716 Nite White 16% - At-home 2 weeks / 8 hrs per night mild 8.04 55
13 Matis, 200716 Brite Smile - 15% in-office 3 X 20 min  - 7.9 68
14 Tsuburu, 200537 Opalescence 10%  - At-home 2 weeks / 8 hrs per night mild 7.78  -
15 Mokhlis, 200012
Opalescence Tooth Whitening 
Gel PF
20%  - At-home 2 weeks / 1hour X2 daily - 7.6 - 
16 Matis, 200716 ArcBrite - 30% in-office 3 X 20 min  - 6.8 53
17 Bernardon, 201032 Whiteness HP maxx FGM  - 35% in-office
2 sessions / 3 applications of 
15 min / 15 day interval
 - 6.64  -
18 Matis, 200716 Accelerated  - 40% and 30% in-office 5 X 3 Min - 6.6 82
19 Bizhang, 20094 illumine Home 10%  - At-home 2 weeks / 8 hrs per night  - 6.57 24
20 Matis, 200716 Zoom!  - 25% in-office X3 / 20 min  - 6.4 50
21 Bernardon, 201032 Whiteness HP maxx FGM - 35% in-office
2 sessions, 3 applications per 
session, 15 day interval
- 6.17 - 
22 Matis, 200716 PolaOffice - 35% in-office X3 / 12 min  - 5.9 69
23 ishikawa-Nagal, 20042 Opalescence PF 10%  - At-home 2 weeks / 4 hours daily mild 5.84  -
24 Bizhang, 20094 illumine Office 15% - in-office 45 min / X3 over 3 weeks - 5.77 20
25 Gurgan, 200915 Laser-White 1--Laser Smile  - 37% in-office X3 / 8 min mild 5.69 - 
26 Gurgan, 200915 Oplasecence Xtra Boost  - 38% in-office X2 /15 min - 5.54  -
27 Matis, 200716 illumine  - 15% in-office X3 / 20 min  - 5.5 36
28 Gurgan, 200915 By White-Biowhite  - 38% in-office X2 / 20 min  - 5.43 - 
29 Matis, 200716 One-hour Smile  - 35% in-office X3 /15 min - 5.4 54
30 Zekonis, 200313 StarBrite 35% - in-office X2 / 3x 10min mild 5.32 32
31 Grobler, 201038 Nite White ACP 10% - At-home 2 weeks / 8 hrs per night low 5.29 27
32 Grobler, 201139 Nite White ACP 10%  - At-home 2 weeks / 8 hrs per night low 5.29 31
33 Gurgan, 200915 Remewhite-Remecure - 35% in-office X3 / 20 min - 5.28  -
34 Benbachir, 200840 Vivastyle Paint On Plus  - 6% in-office
3 days over 2 weeks / 10min 
X5 times per session
- 5.25 - 
35 Grobler, 201139 Opalescence PF 10% - At-home 2 weeks / 8 hrs per night low 5.2 18
36 ishikawa-Nagal, 20042 Nite White Excel 10% - At-home 2 weeks / 4 hours daily mild 5.03 - 
37 Luo, 200741 Crest White Strips - 6% At-home 2 weeks / 30 min X2 daily  - 4.95  --
38 Meireless, 200834 Whiteness Perfect 16%  - At-home 3 weeks / x2 hrs daily  - 4.6 2
39 Gerlach, 200242 Crest Professional Whitestrips - 6.50% At-home 2 weeks / 30 min X2 daily - 4.55  -
40 Meireless, 200834 Whiteness Perfect 10%  - At-home 3 weeks / X2 hours daily  - 4.3 9
41 Bizhang, 20094 Whitestrips -  6% At-home 2 weeks / 30 min X2 daily  - 3.58 16
42 Salem, 201043 Yotuel Special  - 35% in-office 20 min X3 (1 session) mild 3.56 53
43 Grobler, 201044 Opalescence PF 10% - At-home 2 weeks / 8 hrs per night low 3.25 8
44 Karpinia, 200245 Professional crest Whitestrips  - 6.50% At-home 3 weeks / 30 min X2 daily mild 3.15 - 
45 Gerlach, 200242 Nite White Excel 2-tray system 10% - At-home 2 weeks / X2 hour daily - 2.55 - 
46 Al Shethri, 200331 Opalescence Xtra Boost  - 38% in-office
2 treatments 1 week apart / 
X3 daily for 10 min
mild 2.45  -
47 Al Shethri, 200331 Star Brite  - 35% in-office
2 treatments 1 week apart /
X3 daily for 10 min
mild 2.31 - 
48 Karpinia, 200245 Nite White Excel2 10%  - At-home 2 weeks / 2 hours daily mild 1.94  -
49 Luo, 200741 Colgate Great regular Flavour  - 0% (control) At-home 2 weeks / x1 min x2 daily  - 1.27  -
Column 1: Study number
Column 2: Author(s) 
Column 3: Product tested
Column 4: % age carbamide peroxide
Column 5: % age hydrogen peroxide
Column 6: Category of bleaching (at home, in office,  combination)
Column 7: Schedule of bleaching process
Column 8: Resultant tooth sensitivity
Column 9: immediate tooth colour improvement
Column 10: Relapse after four weeks or longer
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(total colour change) which indicate the colour improvement 
as measured numerically and column 10 the percentage re-
lapse as calculated from the ∆E*ab values. This table was 
also sorted according to highest to lowest ∆E*ab values 
(column 9) immediately after treatment.
dIScuSSIon
The values of shade guides cannot be directly compared 
with those numerically measured. A shade guide provides 
only a combination value for the three colour components 
(e.g. L*, a* and b*). The linear rankings of a tooth shade guide 
are not the same as those obtained from sequential delta 
E* (∆E*). The shades represented on a shade guide are not 
equi-distant when measured by the scientific and objective 
distances delta E* which relies on the three colour compo-
nents (ie. L*, a* & b*). The distances between before and af-
ter colour measurements on each treated tooth differ when 
estimated with shade guides or taken numerically and these 
values could not be directly compared. Hence these data 
are assembled separately in two tables (Table 1 and Table 2).
 As ∆E* is a difference between two values the percentage 
change could only be determined in the relapse phase when 
there are indeed two such ∆E*values. in relapse calculations 
where both methods had been used to determine the chang-
es (a few cases only), the percentage relapses determined by 
shade guide and by numerical methods were first separately 
calculated and the average of the two then noted.
 
The percentage improvement (Table 2) could not be cal-
culated for studies where only ∆E*ab values were given 
as ∆E*ab gives the difference between the tooth colour at 
base-line and that after treatment.
For the shade guide values, (Table 1), the top ten achievers were 
at-home products and likewise according to ∆E*ab (Table 2) 
the top ten achievers were also at-home products. The high-
est values reported (Tables 1 and 2) were with a 10% or 15% 
carbamide peroxide treatment over a relatively long treatment 
period (two weeks 6/8 hours per night). in general, the treatment 
periods for top achievers (Table 1 and 2) were all scheduled over 
relatively long time-periods which, as seen in Table 1, varied from 
two hours/day for two weeks, to six hours/night for two weeks 
and to eight hours/night for two weeks. For Table 2 the first eight 
study achievers were for eight hours/night for two weeks (with 
the exception of study # 5 which was for one hour twice daily for 
two weeks. The shortest treatment period (Table 1) within the ten 
top achievers (study # 6 and 7) was one hour/twice-a-day for 14 
days but this was a trial using 7.5% HP (~25% CP) and 20% CP 
in comparison with the more general treatment which uses 10% 
carbamide peroxide. in Table 2 the shortest treatment period 
within the top ten at-home achievers was twice a day for 15 min 
(study # 9) but as for Table 1, this study relied on a high peroxide 
concentration (5.9% HP). The other treatment with a short ap-
plication time was with chlorite (study # 10). Therefore, it can be 
deduced that to obtain the same success rate as with 10% car-
bamide peroxide it seems that a shorter treatment period might 
be indicated but using a higher peroxide concentration.
in general, it can be seen that in-office treatments (even 
with high peroxide concentrations) were far less successful 
(Table 1 and 2) than at-home treatments with ~10% carbamide 
peroxide. On the ranking list, in-office applications came in 
well below the highest achievers at study # 11 (Table 1) and 
study # 11 (Table 2). Why then is the high peroxide concen-
tration treatment unexpectedly found to be less successful? 
The reason may be found in the length of the application pe-
riod. in-office applications (Table 1, studies # 11-17; Table 2, 
study 11 and others) were performed over a short period in 
comparison with the dentist supervised at-home treatment 
procedures. The in-office treatment periods were normally 
short bursts, for example three x 15minutes/session, three x 
20 minutes/session, etc. (Table 1 and 2). However, there were 
a few examples (Table 1, # 40, 49-52) where the in-office ses-
sions were repeated over days but only two of these studies 
(Table 1, #11, 16) were further extended to an at-home treat-
Table 3: Descriptive statistics of colour improvement (shade guide 
assessment) immediately after treatment for ‘At-home’ and ‘in-
office’ treatment.
Category
Values At-home In-office
Number of studies 40 19
Number of studies indicating % colour 
improvement 
19 9
Average of average of % colour 
improvements 
39.3% 38.8%
Std Dev of % colour improvement 22.4% 12.7%
Min % colour improvement 6.9% 19.1%
Max % colour improvement 88.1% 54.4%
Table 4: Descriptive statistics of colour relapse (shade guide as-
sessment) after four weeks for ‘At-home’ and ‘in-office’ treatment. 
Category
Values At-home In-office
Number of studies 40 19
Number of studies indicating % colour 
relapse after 4 weeks
19 9
Average of average % colour relapses after 
4 weeks
13.1% 55.2%
Std Dev of % colour relapse after 4 weeks 17.0% 20.2%
Min % colour relapse after 4 weeks 0.0% 18.0%
Max % colour relapse after 4 weeks 55.0% 81.0%
Table 5: Descriptive statistics of colour improvement (∆E*ab -scale) 
immediately after treatment for ‘At-home’ and ‘in-office’ treatment.  
Category
Values At-home In-office
Number of studies 29 20
Number of studies indicating colour im-
provement
13 11
Average of average ∆E*ab after treatments 6 .36 5.60
Std Dev of ∆E*ab after treatment 2.80 1.48
Min  ∆E*ab after treatment 1.27 2.31
Max  ∆E*ab after treatment 12.32 8.1
Table 6: Descriptive statistics of colour relapse (∆E*ab - scale) after 
4 weeks for ‘At-home’ and ‘in-office’ treatment.
Category
Values At-home In-office
Number of studies 29 20
Number of studies indicating % colour 
relapse 
13 11
Average of average of % colour relapses 26.02% 53.60%
Std Dev of % colour relapses 18.98% 18.65%
Min % colour relapse 2.17% 20.45%
Max % colour relapse 57.37% 81.82%
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ment. However, to allow subjects to personally handle such 
a high peroxide concentration is very risky and should not be 
recommended.
There are probably two main reasons for the short applica-
tion period of in-office treatments: the first reason is financial, 
in that the longer the in-chair session the more expensive 
the treatment becomes, the second is that high peroxide 
application has a possible hazardous effect (related to the 
oxidising strength) on the soft tissue of the oral cavity.
From Table 3 (shade guide) it can be deduced that over-
all both at-home (39.3%) and in-office (38.8%) treatments 
showed more or less the same initial colour improvement. 
However, a major difference could be seen in the relapse 
after a four week or longer period (at-home 13.1%; in-office 
55.2% :Table 4). From the ∆E*ab (Table 5) numerical values, 
the initial colour improvements for in-office and at-home 
were also about the same (5.60 against 6.36).
 
When the relapse was calculated from ∆E*ab values 
(Table 6), in-office treatment gave a value of 53.6%, similar to 
that found with the shade guide assessments (55.2%) (Ta-
ble 4). However, the at-home relapse was 26.02% (Table 6) 
which is about double that when calculated from shade guide 
measurements (13.1%) (Table 4).
Other findings reported on the combination of dentally su-
pervised at-home treatments: Leonard et al.33 revealed that 
the whitening effected by 10% carbamide peroxide (Nite 
White Classic; eight to ten hours per day for 14 days) re-
ported five tabs lighter teeth, an effect which lasted over 
a 3.8 year period. in two different articles 46,47 reporting on 
10% carbamide peroxide which was applied for two hours 
per day for three weeks, no relapse was reported after one 
year. No comparable results were reported for any in-office 
treatment. Only two studies reported results for a combi-
nation of in-office and at-home treatments (Studies # 11 
and 16). Study 11 showed a colour improvement of 56% 
(Table 1) and study 16 also showed a high colour improve-
ment of 53%. These results may indicate that a combination 
of the in-office and at-home treatments could produce the 
most positive results. Unfortunately no assessment on any 
colour relapse was reported in these two studies.
The most commonly tested product was Opalescence 
PF, a material evaluated in 11 studies. The average of the 
average colour improvements as reflected on the shade 
guide scale, was 54% compared with 36% for all the other 
products. With regard to numerical measurements, the 
five studies using that method of assessment recorded 
6.9 (∆E*) for the average of the average colour improve-
ments for Opalescence PF and an average of 5.95 (∆E*) 
for all the other products. These values can be considered 
high spectrophotometer readings, possibly highlighting 
the accuracy of the technology in comparison with shade 
guide measurements.
 
The mean relapse measured numerically after four weeks 
was 27.8% for Opalescence (n=3) which is considerably 
lower than the mean of 40.2% recorded for all the other 
products (n=21). Not all studies recorded relapse values 
(Opalescence 3 of 5; other products: 21 of 44) and these 
findings should therefore be regarded only as an indication 
of relapse potentials.
The next question which may be posed is which of the in-
office or dentist supervised at-home treatments would give 
the lowest tooth sensitivity scores? Not all studies reported 
on this, but the data recorded in Tables 1 and 2 reveals 
no significant differences in tooth sensitivities between the 
routines, and overall these effects were low - with an excep-
tion of the two top achievers in bleaching (Table 1), where a 
higher sensitivity was in fact noted (62% and 45%). However, 
it should also be observed that in some instances during 
treatments, the sensitivity might be so high that the individ-
ual prefers to terminate the application. Some of the manu-
facturers (studies # 1 and 4) added chemicals (potassium 
nitrate and fluoride) to their bleaching products in an attempt 
to counteract sensitivity. However, the clinical data (Table 
1) indicates uncertainty on the possible positive effects of 
those materials, or on amorphous calcium phosphate and 
no general conclusion could be reached.11,16,17,38,48,49 Further-
more, from the published results (Tables 1 and 2), it can also 
be concluded that in general, where tooth sensitivity was 
noted during the whitening process, it disappeared sponta-
neously after the treatment period.
concLuSIon
This analysis of the data shows that the dentist-supervised-
at-home-bleaching and the in-office treatment gave nearly 
the same initial tooth whitening improvement. However, the 
relapse after a four week or longer period was found to be 
much higher for the in-office treatment at a relapse of ~55% 
on average, while the at-home treatment showed a much low-
er relapse over the same period of about 13% to 26%. Overall, 
it can be concluded that the treatment of choice should be a 
dentist supervised at-home bleaching process using a prod-
uct which in general contains about 10% carbamide peroxide 
applied over ~14 days and for ~8 hours per night on average. 
Tooth sensitivity should not be seen as a consistent problem 
although some subjects might choose to discontinue treat-
ment as a result of experiencing the problem.
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